Month: September 2021

DAYTONA BEACH, Fla., Sept. 28, 2021 (GLOBE NEWSWIRE) — TopBuild Corp. (NYSE:BLD), the leading installer and distributor of insulation and building material products in the United States, announced that after a more than 42-year career in finance and over six years with TopBuild, John Peterson, will be retiring from his position as Vice President and Chief Financial Officer of the Company effective March 31, 2022. At that time, Robert (“Rob”) Kuhns, Vice President and Corporate Controller, will assume the CFO position. “I want to thank John for his leadership and many contributions to TopBuild,” said Robert Buck, President and CEO of TopBuild. “John and I have worked together for over 11 years, and I couldn’t have had a better business partner and teammate. John has played a key role in TopBuild’s growth and success and has built...

SAN DIEGO, Sept. 28, 2021 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leading developer of next-generation lithium-ion battery safety and thermal management technologies, today announced that CEO Michael Mo will participate in a Fireside Chat with Alliance Global Partners (“A.G.P.”) on Thursday, September 30, 2021 at 12:00 p.m. Eastern time.The event will feature a KULR corporate presentation followed by Q&A session between CEO Michael Mo and A.G.P. Managing Director, Senior Research Analyst Jake Sekelsky. Following the Q&A session, audience members will be able to ask questions live. The event will be webcast live and available for replay here. About KULR Technology Group Inc. KULR Technology Group Inc. (NYSE American: KULR) develops, manufactures...

CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in a fireside chat during the Chardan Virtual 5th Annual Genetic Medicines Conference on Tuesday, Oct. 5, 2021 at 8:00 a.m. ET. The live webcast will be available in the investor section of the company’s website at www.beamtx.com. The webcast will be archived for 60 days following the presentation. About Beam Therapeutics Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery...

Figure 1Surface Map – Monique Gold Trend new drillingHighlights:New results from the 2021 drill program surrounding the Former Monique Mine show good continuity of the gold zones, which are still open along strike and at depth Expansion drilling continues to return impressive results, including 21.8 g/t Au over 2.0 metres, 7.2 g/t Au over 4.1 metres, 6.5 g/t Au over 4.8 metres, 1.9 g/t Au over 10.9 metres, 1.6 g/t Au over 16.0 metres and 1.5 g/t Au over 44.8 metres between surface and 500 metres vertical depth Infill drilling results continue to confirm gold mineralization continuity, with highlights of up to 1.3 g/t Au over 35.7 metres and 0.9g/t Au over 54.0m east of the Former Monique open pit, between surface and 100 metres vertical depth Three drills active on the Val-d’Or East Project – Drill program increased...

Duet releases video depicting mechanism of action for its proprietary CpG-STAT3 inhibitors to coincide with Duet presentations at OTS Meeting NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, announced today that Duet Therapeutics, a wholly-owned subsidiary of Scopus, will release scientific data during the 17th Annual Meeting of the Oligonucleotide Therapeutics Society. The meeting will conclude on Wednesday, September 29, 2021. Alan Horsager, Ph.D., President and Chief Executive Officer of Duet and President — Immuno-Oncology of Scopus, will present DUET-01: Bispecific Oligonucleotide Targeting TLR9 and STAT3 Signaling for B Cell Lymphoma Immunotherapy...

Figure 1Wabash property – Tr-GB1 results and IP-16 anomalyMONTREAL, Sept. 28, 2021 (GLOBE NEWSWIRE) — Kintavar Exploration Inc. (the “Corporation” or “Kintavar”) (TSX-V: KTR), is very pleased to announce new exploration results from the Cloutier area located on its Wabash property. The results include the first direct grab samples from the strongest geophysical “IP” anomaly. Follow-up over this anomaly had been a priority for this summer exploration program. TR-GB1 resultsThe IP survey that was conducted last winter had identified a very strong chargeability and resistivity anomaly (PP-16) that extended for over 1.7 km (see new release February 16, 2021). Initial attempts for trenching in the strongest portion of the anomaly encountered significant amounts of overburden or access constraints. Trench TR-GB1 was...

(All amounts expressed in U.S. dollars unless otherwise noted) TORONTO, Sept. 28, 2021 (GLOBE NEWSWIRE) — Agnico Eagle Mines Limited (TSX:AEM, NYSE:AEM) (“Agnico Eagle” or the “Company”) and Kirkland Lake Gold Ltd. (TSX:KL, NYSE:KL, ASX:KLA) (“Kirkland Lake Gold”) announced today that they have entered into an agreement (the “Merger Agreement”) to combine in a merger of equals (the “Merger”), with the combined company to continue under the name “Agnico Eagle Mines Limited”. The Merger will establish the new Agnico Eagle as the gold industry’s highest-quality senior producer, with the lowest unit costs, highest margins, most favourable risk profile and industry-leading best practices in key areas of environmental, social and governance (“ESG”). Upon closing of the Merger, the Company is expected to have $2.3 billion of available...